FDA 483 - Cosco Enterprises Inc. - March 26, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Cosco Enterprises Inc., an OTC drug manufacturer in Ridgewood, NY, revealed ten significant deficiencies in their manufacturing and quality control processes for Tincture of Green Soap U.S.P. The observations highlight systemic failures in stability testing, raw material control, process validation, batch record completeness, and personnel training. Notably, several issues were repeat observations from prior inspections, indicating a lack of sustained corrective action.
ID · ec4deb4f-bb8f-4ec1-80d0-078a7ddfb129